ENVB
Enveric Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.39
−3.47%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-22.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Dec 30, 2025 | DeWitt Sheila · director | A-Award | 7,633 | $0.00 |
| Dec 30, 2025 | Kegler George A. · director | A-Award | 7,633 | $0.00 |
| Dec 30, 2025 | PASQUALONE FRANK · director | A-Award | 7,633 | $0.00 |
| Dec 30, 2025 | Schabacker Marcus · director | A-Award | 7,633 | $0.00 |
| Dec 30, 2025 | Tucker Joseph Edward · director, officer: Chief Executive Officer | A-Award | 60,296 | $0.00 |
| Dec 30, 2025 | WEBB MICHAEL D · director | A-Award | 7,633 | $0.00 |
| Dec 30, 2025 | Coveney Kevin Michael · officer: Chief Financial Officer | A-Award | 40,198 | $0.00 |
| May 12, 2025 | Coveney Kevin Michael · officer: CHIEF FINANCIAL OFFICER | A-Award | 74,150 | $0.00 |
| May 12, 2025 | Facchini Peter J. · officer: CHIEF INNOVATION OFFICER | A-Award | 24,717 | $0.00 |
| May 12, 2025 | Tucker Joseph Edward · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 98,866 | $0.00 |
| Oct 11, 2024 | DeWitt Sheila · director | A-Award | 27,845 | $0.00 |
| Oct 11, 2024 | Kegler George A. · director | A-Award | 47,733 | $0.00 |
| Oct 11, 2024 | Schabacker Marcus · director | A-Award | 47,733 | $0.00 |
| Oct 11, 2024 | WEBB MICHAEL D · director | A-Award | 47,733 | $0.00 |
| Oct 11, 2024 | PASQUALONE FRANK · director | A-Award | 47,733 | $0.00 |
| Oct 11, 2024 | Tucker Joseph Edward · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 161,633 | $0.00 |
| Oct 11, 2024 | Facchini Peter J. · officer: CHIEF INNOVATION OFFICER | A-Award | 40,000 | $0.00 |
| Oct 11, 2024 | Coveney Kevin Michael · officer: CHIEF FINANCIAL OFFICER | A-Award | 100,000 | $0.00 |
| Feb 26, 2024 | Tucker Joseph Edward · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 100,000 | $0.00 |
| Feb 26, 2024 | Facchini Peter J. · officer: CHIEF INNOVATION OFFICER | A-Award | 50,000 | $0.00 |
| Feb 26, 2024 | Coveney Kevin Michael · officer: CHIEF FINANCIAL OFFICER | A-Award | 60,000 | $0.00 |
| Sep 19, 2023 | PASQUALONE FRANK · director | Purchase | 1,000 | $2.14 |
| Mar 14, 2023 | Coveney Kevin Michael · officer: Chief Financial Officer | A-Award | 26,500 | $0.00 |
| Jan 27, 2023 | Facchini Peter J. · officer: Chief Innovation Officer | A-Award | 17,000 | $0.00 |
| Jan 27, 2023 | Hagel Jillian Marie · officer: Vice President of Innovation | A-Award | 12,000 | $0.00 |
| Jan 27, 2023 | Kanubaddi Avani · officer: President and COO | A-Award | 10,000 | $0.00 |
| Jan 27, 2023 | Tucker Joseph Edward · officer: Chief Executive Officer | A-Award | 44,000 | $0.00 |
| Jan 25, 2023 | Hagel Jillian Marie · officer: Chief Technology Officer | A-Award | 10,500 | $0.00 |
| Jan 25, 2023 | Hagel Jillian Marie · officer: Chief Technology Officer | A-Award | 1,021 | $0.00 |
| Jan 25, 2023 | Facchini Peter J. · officer: Chief Scientific Officer | A-Award | 10,500 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 3Increased 2Reduced 1Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 32,149 | May 15, 2026 |
| ADVISORSHARES INVESTMENTS LLC | Unchanged | 16,974 | Apr 28, 2026 |
| CITADEL ADVISORS LLC | New Position | 13,965 | Sep 2, 2026 |
| UBS GROUP AG | Increased | 3,612 | May 5, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 1,103 | May 15, 2026 |
| JONES FINANCIAL COMPANIES LLLP | New Position | 1,000 | May 15, 2026 |
| SBI SECURITIES CO., LTD. | Increased | 83 | Apr 28, 2026 |
| BLACKROCK, INC. | Unchanged | 51 | May 13, 2026 |
| GROUP ONE TRADING, L.P. | Unchanged | 1 | May 13, 2026 |
| DANSKE BANK A/S | Unchanged | 1 | May 12, 2026 |
| NATIONAL BANK OF CANADA /FI/ | Unchanged | 1 | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 1 | Jul 8, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| BlackRock, Inc. | Sold Out | 0 | May 13, 2026 |
| DANSKE BANK A/S | Sold Out | 0 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Dec 30, 2025